Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter

IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

See all formats and pricing
More options …
Volume 41, Issue 7


Fluorometric Assays of Phospholipase A2 Activity with Three Different Substrates in Biological Samples of Patients with Schizophrenia

Jürgen Lasch / Ingo Willhardt / Daniel Kinder / Heinrich Sauer / Stefan Smesny
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2003.138


The rationale of this study was to understand the complexity of kinetics of fluorogenic phospholipid substratesas well as contradictory findings of clinical papers measuring phospholipase A2 (PLA2) activity using different methodologies. The aim was to recommend to clinicians and researchers what substrate in conjunction with what assay should be used. Two methods, (i) continuous fluorometric assay and (ii) high performance thin layer chromatography (HPTLC) on microplates combined with quantitative image scanning, were studied with three different substrates (bis-BODIPY® FL C11-PC, NBDC6-HPC®, PED6®).

The study demonstrates that NBD-PC is not a suitable substrate to measure PLA2 activity using a spectrofluorometer. On the other hand, NBD-PC gives the highest and most reproducible integrated light intensities (ILIs) in HPTLC studies. Slow time-dependent increases in fluorescence intensities recorded with biological samples in fluorometers, but not caused by substrate splitting, had to be classified as “perturbation kinetics”. PLA2 activities in blood samples of 26 unmedicated schizophrenia patients and 26 age-matched healthy controls were measured by the spectrofluorometric method and then compared with the activity data obtained with the HPTLC method. A significant group difference was found only with the HPTLC.

In order to get more reliable results, we recommend that clinicians and researchers use NBD-phosphatidylcholines as PLA2 substrates in biological samples and start with an analytical separation of reaction products followed by image analysis of the fluorescent spots.

About the article

Published Online: 2005-06-01

Published in Print: 2003-07-21

Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 41, Issue 7, Pages 908–914, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2003.138.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Sergej Nadalin, Jelena Rebić, Vesna Šendula Jengić, Vjekoslav Peitl, Dalibor Karlović, and Alena Buretić-Tomljanović
Prostaglandins, Leukotrienes and Essential Fatty Acids, 2019, Volume 148, Page 9
Robert K. McNamara, Ronald Jandacek, Therese Rider, Patrick Tso, Chang-Gyu Hahn, Neil M. Richtand, and Kevin E. Stanford
Schizophrenia Research, 2007, Volume 91, Number 1-3, Page 37
Chuangye Xu, Xuhan Yang, Liya Sun, Tianqi Yang, Changqun Cai, Peng Wang, Jie Jiang, Ying Qing, Xiaowen Hu, Dandan Wang, Pengkun Wang, Gaoping Cui, Juan Zhang, Yan Li, Feng Ji, Chuanxin Liu, and Chunling Wan
Psychiatry Research, 2019, Volume 273, Page 782
Athanassios Karkabounas, Dimitra G. Georgiadou, Panagiotis Argitis, Vassilios Psycharis, George Nakos, Agni M. Kosmas, and Marilena E. Lekka
Lipids, 2015, Volume 50, Number 12, Page 1259
Rosita Primavera, Martina Di Francesco, Antonella De Cola, Vincenzo De Laurenzi, Donatella Paolino, Matteo Ciancaioni, Maria Carafa, Christian Celia, Carmine Di Ilio, Antonio Di Stefano, Massimo Fresta, Marcello Locatelli, and Luisa Di Marzio
Colloids and Surfaces B: Biointerfaces, 2015, Volume 135, Page 575
A.S. Alekseeva, A.A. Korotaeva, E.V. Samoilova, P.E. Volynsky, E.L. Vodovozova, and I.A. Boldyrev
Biochemical and Biophysical Research Communications, 2014, Volume 454, Number 1, Page 178
Tina Kamčeva, Maja Radisavljević, Iva Vukićević, Jürgen Arnhold, and Marijana Petković
Chemistry & Biodiversity, 2013, Volume 10, Number 11, Page 1972
S Smesny, B Milleit, U-C Hipler, C Milleit, M R Schäfer, C M Klier, M Holub, I Holzer, G E Berger, M Otto, I Nenadic, M Berk, P D McGorry, H Sauer, and G P Amminger
Molecular Psychiatry, 2014, Volume 19, Number 3, Page 317
Stefan Smesny, Berko Milleit, Igor Nenadic, Christoph Preul, Daniel Kinder, Jürgen Lasch, Ingo Willhardt, Heinrich Sauer, and Christian Gaser
NeuroImage, 2010, Volume 52, Number 4, Page 1314
Stefan Smesny, Christina Kunstmann, Sebastian Kunstmann, Ingo Willhardt, Juergen Lasch, Rachel A. Yotter, Tina-Marie Proffitt, Melissa Kerr, Conny Marculev, Berko Milleit, Christine Milleit, Igor Nenadic, Paul Amminger, Patrick D. McGorry, Heinrich Sauer, and Gregor E. Berger
The World Journal of Biological Psychiatry, 2011, Volume 12, Number 8, Page 598
S. Smesny, T. Rosburg, S. Riemann, K. Baur, N. Rudolph, G. Berger, and H. Sauer
Prostaglandins, Leukotrienes and Essential Fatty Acids, 2005, Volume 72, Number 6, Page 393
Stefan Smesny, Daniel Kinder, Ingo Willhardt, Timm Rosburg, Jürgen Lasch, Gregor Berger, and Heinrich Sauer
Biological Psychiatry, 2005, Volume 57, Number 4, Page 399
Stefan Smesny, Susan Stein, Ingo Willhardt, Jürgen Lasch, and Heinrich Sauer
Journal of Neural Transmission, 2008, Volume 115, Number 8, Page 1173
M H Law, R G H Cotton, and G E Berger
Molecular Psychiatry, 2006, Volume 11, Number 6, Page 547

Comments (0)

Please log in or register to comment.
Log in